Ergo Science Corp
OTC:ERGN
P/B
Price to Book Value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
Market Cap | P/B | ||||
---|---|---|---|---|---|
US |
Ergo Science Corp
OTC:ERGN
|
55.2B USD | 3 185.8 | ||
CA |
A
|
Advance Lithium Corp
XTSX:AALI
|
540.8B CAD | 2 060 936.6 | |
US |
V
|
Viveon Health Acquisition Corp
NYSE-MKT:VHAQ
|
332.4B USD | 100 740.8 | |
US |
G
|
Gould Investors LP
OTC:GDVTZ
|
304.4B USD | 0 | |
US |
C
|
Carson Energy Development Corp
OTC:CDVM
|
270.6B USD | -822 614 | |
IN |
S
|
SAB Industries Ltd
BSE:539112
|
2.9B INR | 0.7 | |
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
77.1B Zac | 0 | |
US |
Liberty Bancshares Inc
OTC:LBSI
|
55.5B USD | 0 | ||
US |
H
|
HK Graphene Technology Corp
OTC:HKGT
|
53.9B USD | -18 316.7 | |
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
692.5T IDR | 0 | ||
US |
Coupang Inc
F:788
|
38.4B EUR | 10.1 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.